Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes

Molecular and Cellular Biology

Volumn 32, Issue 15, 2012, Pages 2979-2991

  Tabariès, Sébastien ^a,b   Dupuy, Fanny ^a,c   Dong, Zhifeng ^a,b   Monast, Anie ^a,b   Annis, Matthew G ^a,b   Spicer, Jonathan ^d   Ferri, Lorenzo E ^d   Omeroglu, Atilla ^d   Basik, Mark ^e,f   Amir, Eitan ^g   Clemons, Mark ^g   Siegel, Peter M ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 2; FIBRONECTIN; GELATINASE A; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 5;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL ADHESION; CELL INTERACTION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; LIVER METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION; TROPISM; TUMOR CELL;

EID: 84864619220     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00299-12     Document Type: Article

References (52)

1. Aung PP, et al. 2006. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch. 448:428- 434.
2. Chao Y, Wu Q, Shepard C, Wells A. 2012. Hepatocyte induced reexpression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clin. Exp. Metastasis 29:39 -50.
3. Chao YL, Shepard CR, Wells A. 2010. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol. Cancer 9:179.
4. Cocco E, et al. 2010. Clostridium perfringens enterotoxin carboxyterminal fragment is a novel tumor-homing peptide for human ovarian cancer. BMC Cancer 10:349. doi:10.1186/1471-2407-10-349.
5. Colegio OR, Van Itallie C, Rahner C, Anderson JM. 2003. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am. J. Physiol. Cell Physiol. 284:C1346 -C1354.
6. Daugherty BL, Ward C, Smith T, Ritzenthaler JD, Koval M. 2007. Regulation of heterotypic claudin compatibility. J. Biol. Chem. 282: 30005-30013.
7. Dhawan P, et al. 2011. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. Oncogene 30:3234 -3247.
8. Escudero-Esparza A, Jiang WG, Martin TA. 2011. The claudin family and its role in cancer and metastasis. Front. Biosci. 16:1069 -1083.
9. Fujita K, et al. 2000. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 476:258 -261.
10. Furuse M, Furuse K, Sasaki H, Tsukita S. 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 153:263-272.
11. Furuse M, Sasaki H, Tsukita S. 1999. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J. Cell Biol. 147:891-903.
12. Hess KR, et al. 2006. Metastatic patterns in adenocarcinoma. Cancer 106:1624 -1633.
13. Hugo H, et al. 2007. Epithelial-mesenchymal and mesenchymalepithelial transitions in carcinoma progression. J. Cell. Physiol. 213:374- 383.
14. Joyce JA, Pollard JW. 2009. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9:239 -252.
15. Jung H, Jun KH, Jung JH, Chin HM, Park WB. 2011. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. J. Surg. Res. 167:e185- e191.
16. Kakutani H, et al. 2010. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin. Eur. J. Pharm. Biopharm. 75:213-217.
17. Kemperman H, Driessens M, La Riviere G, Meijne AM, Roos E. 1994. The role of integrins and integrin activation in liver metastasis. Invasion Metastasis 14:98 -108.
18. Kemperman H, Wijnands Y, de Rijk D, Roos E. 1993. The integrin alpha 6 beta 4 on TA3/Ha mammary carcinoma cells is involved in adhesion to hepatocytes. Cancer Res. 53:3611-3617.
19. Kemperman H, Wijnands Y, Meijne AM, Roos E. 1994. TA3/St, but not TA3/Ha, mammary carcinoma cell adhesion to hepatocytes is mediated by alpha 5 beta 1 interacting with surface-associated fibronectin. Cell Adhes. Commun. 2:45-58.
20. Kim TH, et al. 2008. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 53:48 -55.
21. Kinugasa T, et al. 2007. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res. 27:3729 -3734.
22. Kojima T, Sawada N. 2011. Expression and function of claudins in hepatocytes. Methods Mol. Biol. 762:233-244.
23. Lacerte A, et al. 2008. Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell. Signal. 20:50 -59.
24. Langley RR, Fidler IJ. 2011. The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int. J. Cancer 128:2527-2535.
25. Lim TS, Vedula SR, Hunziker W, Lim CT. 2008. Kinetics of adhesion mediated by extracellular loops of claudin-2 as revealed by singlemolecule force spectroscopy. J. Mol. Biol. 381:681- 691.
26. Lopez-Rovira T, Chalaux E, Massague J, Rosa JL, Ventura F. 2002. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277:3176 -3185.
27. Marceau N, Gilbert S, Loranger A. 2004. Uncovering the roles of intermediate filaments in apoptosis. Methods Cell Biol. 78:95-129.
28. Mathew J, Galarneau L, Loranger A, Gilbert S, Marceau N. 2008. Keratin-protein kinase C interaction in reactive oxygen species-induced hepatic cell death through mitochondrial signaling. Free Radic. Biol. Med. 45:413- 424.
29. Mego M, Mani SA, Cristofanilli M. 2010. Molecular mechanisms of metastasis in breast cancer-clinical applications. Nat. Rev. Clin. Oncol. 7:693-701.
30. Mina LA, Sledge GW, Jr. 2011. Rethinking the metastatic cascade as a therapeutic target. Nat. Rev. Clin. Oncol. 8:325-332.
31. Mook OR, et al. 2008. Interactions between colon cancer cells and hepatocytes in rats in relation to metastasis. J. Cell. Mol. Med. 12:2052-2061.
32. Mook OR, et al. 2003. Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 38:295-304.
33. Patonai A, et al. 2011. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma. Virchows Arch. 458:679-688.
34. Piontek J, et al. 2008. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 22:146 -158.
35. Polyak K, Weinberg RA. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9:265-273.
36. Roos E, Dingemans KP, Van de Pavert IV, Van den Bergh-Weerman MA. 1978. Mammary-carcinoma cells in mouse liver: infiltration of liver tissue and interaction with Kupffer cells. Br. J. Cancer 38:88 -99.
37. Roos E, Van de Pavert IV, Middelkoop OP. 1981. Infiltration of tumour cells into cultures of isolated hepatocytes. J. Cell Sci. 47:385-397.
38. Rose AA, et al. 2010. ADAM10 releases a soluble form of the GPNMB/ Osteoactivin extracellular domain with angiogenic properties. PLoS One 5:e12093. doi:10.1371/journal.pone.0012093.
39. Rose AA, et al. 2007. Osteoactivin promotes breast cancer metastasis to bone. Mol. Cancer Res. 5:1001-1014.
40. Rosenthal R, et al. 2010. Claudin-2, a component of the tight junction, forms a paracellular water channel. J. Cell Sci. 123:1913-1921.
41. Saeki R, et al. 2010. A claudin-targeting molecule as an inhibitor of tumor metastasis. J. Pharmacol. Exp. Ther. 334:576 -582.
42. Sasaki H, et al. 2003. Dynamic behavior of paired claudin strands within apposing plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 100:3971- 3976.
43. Soini Y. 2004. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum. Pathol. 35:1531-1536.
44. Szasz AM, et al. 2011. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis. Clin. Exp. Metastasis 28:55- 63.
45. Tabariès S, et al. 2011. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene 30:1318 -1328.
46. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelialmesenchymal transitions in development and disease. Cell 139:871- 890.
47. Turksen K, Troy TC. 2004. Barriers built on claudins. J. Cell Sci. 117: 2435-2447.
48. Van Itallie CM, Anderson JM. 2006. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 68:403- 429.
49. Yamaguchi H, et al. 2011. Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells. Cell. Mol. Biol. Lett 16:385-397.
50. Yao Q, et al. 2010. Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers. Biochem. Biophys. Res. Commun. 398:413- 419.
51. Yates CC, Shepard CR, Stolz DB, Wells A. 2007. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br. J. Cancer 96:1246 -1252.
52. Yuan X, et al. 2009. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors. Mol. Cancer Ther. 8:1906 -1915.